Joseph Ruiz, PhD

president

Dr. Joseph Ruiz, President, has over 25 years experience as an investigator in academia and industry in embryonic and adult stem cell biology, genome engineering, hepatic cell biology, cell transplantation, and histotechnology. He frequently serves as a reviewer and chair for NIH Small Business Scientific Review Groups.  Dr. Ruiz’s background of holding positions in both academia and the biotech industry has given him a unique perspective on the importance of developing a comprehensive research plan while also driving research toward clinical or commercial applications. He obtained his PhD  at UC San Diego and completed post-doctoral work at Columbia and Harvard Universities. Dr. Ruiz has held faculty positions at the Indiana School of Medicine and at the Wistar Institute, and has directed scientific development at several biotech startup companies.

Anil Goyal

Board Member

Anil Goyal is an entrepreneurial business development executive with 20+ years of experience leading and growing biotechnology companies that are developing novel, innovative therapies, technologies and discovery platforms. Dr. Goyal has served in leadership roles in several biotech companies - Millennium (MLNM, Acq. by Takeda), Heat Biologics (HTBX), Serenex (Acq. by Pfizer), Optherion (Acq. by Sequenom). He also has extensive experience in strategic planning, licensing, M&A, fund raising from VC, Corp VC, public market, NIH and venture philanthropies.

 

Zefeng Wang, PhD

Scientific Founder
 

Dr. Zefeng Wang, co-founder and CSO, received his Ph.D. degree from Johns Hopkins Medical School serves 9 months per year as Director CAS-MPG Partner Institute for Computational Biology (Shanghai CHINA) and 3 months per year as CSO for Enzerna. Dr. Wang has made significant contribution to the field of RNA biology by developing a series of new methods to study RNA metabolism, including splicing and degradation, and his work has been recognized by several research awards. He his patented technology for “RNA restriction enzymes” forms the basis of Enzerna’s core technology.

 

Don Rose, PhD

Dr. Don Rose, Director, Carolina KickStart, NC TraCS Institute, UNC-Chapel Hill serves on the Executive Board of Enzerna. Dr. Rose’s broad perspective with life science research, product development, seedstage investing, business development, and sales and marketing will be valuable as Enzerna commercializes its technology.